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Intrathymic T-cell differentiation is under the control of the thymic microenvironment, which acts on maturing thymocytes via membrane as well as soluble products. Increasing data show that this process can be modulated by classical hormones, as exemplified herein by prolactin (PRL) and growth hormone (GH), largely secreted by the pituitary gland. Both PRL and GH stimulate the secretion of thymulin, a thymic hormone produced by thymic epithelial cells. Conversely, low levels of circulating thymulin parallel hypopituitary states. Interestingly, the enhancing effects of GH on thymulin seem to be mediated by insulinlike growth factor (IGF-1) since they can be abrogated with anti-IGF-1 or anti-IGF-l-receptor antibodies. The influence of PRL and GH on the thymic epithelium is pleiotropic: PRL enhances in vivo the expression of high-molecular-weight cytokeratins and stimulates in vitro TEC proliferation, an effect that is shared by GH and IGF-1. Differentiating T cells are also targets for the intrathymic action of PRL and GH. In vivo inoculation of a rat pituitary cell line into old rats results in restoration of the thymus, including differentiation of CD4-CD8-thymocytes into CD4+CD8 cells. Furthermore, PRL may regulate the maintenance of thymocyte viability during the double-positive stage of thymocyte differentiation. Injections of GH into aging mice increase total thymocyte numbers and the percentage of CD3-bearing cells, as well as the Concanavalin-A mitogenic response and IL-6 production by thymocytes. Interestingly, similar findings are observed in animals treated with IGF-1. Lastly, the thymic hypoplasia observed in dwarf mice can be reversed with GH treatment. In keeping with the data summarized earlier is the detection of receptors for PRL and GH on both thymocytes and thymic epithelial cells. Importantly, recent studies indicate that both cell types can produce PRL and GH intrathymically. Similarly, production of IGF-1 and expression of a corresponding receptor has also been demonstrated.
In conclusion, these data strongly indicate that the thymus is physiologically under control of pituitary hormones PRL and GH. In addition to the classical endocrine pathway, paracrine and autocrine circuits are probably implicated in such control. Safieh-Garabedian et al., 1992; Kendall and Stebbings, 1994; Boyd et al., 1993 ) that can modulate thymocyte behavior. In this respect, thymulin, one chemically defined thymic hormone is able to induce the expression of CD90--the Thy-1 marker--(see review by Bach, 1983 ) that has been defined as an adhesion molecule able to transduce signals for the intrathymic production of cytokines during thymocyte differentiation (Tentori et al. 1988; He et al., 1991) . In addition to other immune functions (see reviews by Bach, 1983; Safieh-Garabedian et al., 1992) , thymulin acts on neuroendocrine circuits, modulating the secretion of various hypothalamic and pituitary hormones (see reviews by Dardenne and Savino, 1996 Dardenne and Savino, 1994) . In this respect, we will discuss herein the effects of prolactin (PRL) and growth hormone (GH) on various aspects of the thymic microenvironment and T-cell differentiation. Moreover, the intrathymic production of these hormones as well as the expression of corresponding receptors by thymic cells will be analyzed, in an attempt to provide a molecular basis for autocrine, paracrine, and endocrine pathways that may be involved in the action of both PRL and GH on thymus physiology.
THYMIC ENDOCRINE FUNCTION IS INFLUENCED BY PITUITARY HORMONE STATUS
The first demonstration that pituitary hormones can modulate endocrine function came from studies in dwarf mice that exhibit a precocious age-dependent decay of thymulin serum levels (Pelletier et al., 1976) . In keeping with this finding, low thymulin levels are found in hypophysectomized rats and dwarf humans (see reviews by Savino, 1990, 1992; Mocheggiani et al., 1994) . Conversely, adenopituitary hyperactivity states, including prolactinoma and acromegaly, are paralleled by increased levels of serum thymulin (Timsit et al., 1989 (Timsit et al., , 1992 (Gaufo and Diamond, 1996 (Hosokawa et al., 1994) . Lastly, the possibility that PRL influences the shaping of T-cell repertoire is suggested, since it can switch the expression of TCR chains in Nb2 cells (Hosokawa et al., 1996) .
A series of in vivo experiments also evidenced significant changes in thymocyte differentiation under GH influence. Injections of this hormone into aging mice increase total thymocyte numbers and the percentage of CD3-bearing cells (Knyszynski et al., 1992) . In addition, Con-A mitogenic response as well as IL-6 production by thymocytes are enhanced in GH-treated aging animals (Goya et al., 1992) . Interestingly, cyclosporin-A-induced thymic atrophy is restored by in vivo treatment with recombinant GH or IGF-1 (Beschorner et al., 1991) . Lastly, IGF-1 is able to induce repopulation of the atrophic thymus from diabetic rats and mice (Binz et al., 1990; Bergerot et al., 1995) .
The role of GH on thymus development is also stressed by the findings obtained with GH-deficient dwarf mice. In these animals, besides the precocious decline in thymulin serum values (Pelletier et al., 1976) , there is a progressive thymic hypoplasia with decreased numbers of CD4/8 double-positive thymocytes. Iraportantly, such defects can be largely restored by long treatment with GH (Murphy et al., 1992) . It is clear from the data discussed before that a variety of intrathymic changes take place following PRL or GH stimulation, further characterizing the pleiotropic role of these hormones on the thymus.
EXPRESSION OF PROLACTIN AND GROWTH HORMONE RECEPTORS IN THE THYMUS
To bring further support to the data obtained in both experimental models and humans evidencing a role of PRL and GH on thymus physiology, it was obviously necessary to demonstrate receptors for such molecules on thymic cells. Both PRL and GH receptors belong to the haematopoietin-receptor family (that also includes receptors for various cytokines), which appears to be derived from a common ancestral gene that underwent multiple duplications and modifications (see review by Finidori and Kelly, 1995) .
With regard to the PRL receptor, two main forms have been characterized in murine tissues, probably resulting from alternative splicing of a primary transcript (reviewed by Kelly et al., 1993) . Both forms of the receptor were reported in thymic epithelial cells and differentiating thymocytes, as ascertained by distinct methodological approaches (Dardenne et al., 1991; Gagnerault et al., 1993; Nagano and Kelly, 1994; Gunes and Mastro, 1996) . Additionally, anti-PRL receptor antibodies can act as agonists of the natural ligand, thus mimicking PRL in enhancing TEC proliferation and thymulin secretion (Dardenne et al., 1991) . It is also noteworthy that the Concanavalin-A-induced mitogenic response of thymocytes is paralleled by an augmentation of PRL receptor density on thymocyte membranes, suggesting that PRL may be related to intrathymic T-cell activation (Gagnerault et al., 1993 Weigent, 1996) . Intrathymically, PRL expression was detected at the mRNA transcript level (Touraine et al., 1994; Wu et al., 1996a) , and distinct PRL isoforms were seen in Con-A-stimulated murine and human thymocytes (Montgomery et al., 1990 (Montgomery et al., , 1992 . Interestingly, recent in situ hybridization studies revealed PRL mRNA in thymocytes and to a lesser extent in epithelial cells (Wu et al., 1996a) .
Growth hormone production has also been evidenced in TEC, as ascertained by in situ hybridization and immunocytochemistry (Maggiano et al., 1994) . In this study, it was suggested that only a proportion of TEC would be able to constitutively produce GH. By contrast, in a recent study in which the intrathymic production of GH was ascertained by RT-PCR and in situ hybridization, a positive signal for GH mRNA was detected in microenvironmental cells and thymocytes (Wu et al., 1996b) . Accordingly, GH release was detected in TEC as well as in thymocyte cultures (unpublished), thus supporting the hypothesis that Thus, in addition to the classical endocrine pathway, paracrine and autocrine circuits are probably implicated in the PRL/GH control of thymus physiology, as proposed in Fig. 1 . Dissecting such hypothetical intrathymic circuitry will be certainly relevant for a better understanding of how the organ functions in daily life.
